MedTrace Logo

The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation

NCT01289769 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-12-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of dexmedetomidine on hemodynamic responses during laryngoscopy and double lumen endotracheal intubation and assess the adverse effect related to complications of dexmedetomidine.

Conditions

Interventions

DRUG

Dexmedetomidine

dexmedetomidine 0.7 microgram per kilogram in saline 20 ml given within 10 minutes before intubation

DRUG

Placebo

normal saline 20 ml( the same volume as dexmedetomidine) giving within 10 minutes.

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Tanyong Pipanmekaporn, MD · Department of Anesthesiology, Faculty of Medicine, Chiang Mai University , Chiang Mai, Thailand,50200

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Thailand

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289769 on ClinicalTrials.gov